Prime Medicine Ownership | Who Owns Prime Medicine?
Prime Medicine Ownership Summary
Prime Medicine is owned by 45.96% institutional investors, 24.07% insiders, and 29.97% retail investors. Parallel advisors is the largest institutional shareholder, holding 0% of PRME shares. ARK Genomic Revolution is the top mutual fund, with 1.91% of its assets in Prime Medicine shares.
PRME Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Prime Medicine | 45.96% | 24.07% | 29.97% |
Sector | Healthcare Stocks | 278.70% | 10.61% | -189.31% |
Industry | Biotech Stocks | 63.84% | 10.66% | 25.50% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Parallel advisors | - | - | - |
Sherbrooke park advisers | - | - | - |
Point72 asset management | - | - | - |
Metlife investment management | - | - | - |
Exoduspoint capital management, lp | - | - | - |
Massmutual trust co fsb/adv | - | - | - |
Jane street group | - | - | - |
Us bancorp \de\ | - | - | - |
Creative planning | - | - | - |
National bank of canada /fi/ | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Parallel advisors | - | - | - |
Sherbrooke park advisers | - | - | - |
Point72 asset management | - | - | - |
Metlife investment management | - | - | - |
Exoduspoint capital management, lp | - | - | - |
Massmutual trust co fsb/adv | - | - | - |
Jane street group | - | - | - |
Us bancorp \de\ | - | - | - |
Creative planning | - | - | - |
National bank of canada /fi/ | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Federated hermes | - | - | -6.00 |
Massmutual trust co fsb/adv | - | - | -104.00 |
Parallel advisors | - | - | -110.00 |
Allworth financial lp | - | - | -141.00 |
Us bancorp \de\ | - | - | -202.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Westwood group | - | - | -883.13K |
Walleye capital | - | - | -403.74K |
Susquehanna fundamental investments | - | - | -144.72K |
Exoduspoint capital management, lp | - | - | -131.73K |
Jane street group | - | - | -101.76K |
Sold Out
Holder | Change |
---|---|
Federated hermes | -6.00 |
Massmutual trust co fsb/adv | -104.00 |
Parallel advisors | -110.00 |
Allworth financial lp | -141.00 |
Us bancorp \de\ | -202.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 124 | -4.62% | 60,152,185 | -4.70% | 45 | 1.64% | 61 | -12.86% | 35 | 9.38% |
Dec 31, 2024 | 132 | 11.86% | 64,335,371 | -6.37% | 53 | 1.64% | 72 | 35.85% | 32 | 6.67% |
Sep 30, 2024 | 118 | -4.07% | 68,711,038 | -0.26% | 57 | 1.72% | 53 | -24.29% | 30 | - |
Jun 30, 2024 | 123 | 5.13% | 68,888,471 | 3.34% | 57 | 1.42% | 70 | 11.11% | 30 | -9.09% |
Mar 31, 2024 | 117 | 10.38% | 66,659,137 | 37.23% | 63 | 2.24% | 63 | 10.53% | 33 | 17.86% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
ARK Genomic Revolution | 2.50M | 1.91% | 86.27K |
ARK Genomic Revolution ETF | 2.27M | 1.73% | -26.94K |
ARK Disruptive Innovation Full Composite | 2.23M | 1.70% | -237.53K |
Vanguard US Total Market Shares ETF | 2.16M | 1.65% | - |
Vanguard Total Stock Mkt Idx Inv | 2.10M | 1.60% | - |
iShares Russell 2000 ETF | 1.50M | 1.14% | 10.37K |
Nikko AM ARK Disruptive Innovation A USD | 1.31M | 1.00% | - |
T. Rowe Price Small-Cap Value | 1.30M | 0.99% | -279.00 |
Nikko AM ARK Pstv Chg Innovt P JPY Acc | 1.25M | 0.95% | -8.15K |
US Small-Cap Growth II Equity Comp | 1.13M | 0.86% | -15.60K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 30, 2025 | Liu David R. | - | Buy | $52.83K |
Jun 23, 2025 | Liu David R. | - | Buy | $45.40K |
Jun 16, 2025 | Liu David R. | - | Buy | $31.20K |
Jun 11, 2025 | Liu David R. | - | Buy | $33.59K |
May 20, 2025 | Brudnick Richard | Chief Business Officer | Buy | $23.79K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 7 | - |
2025 Q1 | - | - |
2024 Q4 | - | - |
2024 Q2 | - | - |
2024 Q1 | 3 | - |
PRME Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools